Home / Pharmacokinetics Expertise

Advancing PK Insight

Rigorous PK analyses and models for confident decisions.

Clear PK Insight for Better Development Decisions

Pharmacokinetic (PK) science is the foundation of successful drug development, from preclinical discovery to late stage trials. At Evestia Clinical, our PK team partners proactively with sponsors to design and deliver analyses and models that illuminate absorption, distribution, metabolism, and excretion (ADME), support safety and efficacy assessment, and uphold the highest standards of quality and integrity.

We take the time to understand your study’s objectives, protocol nuances, and data architecture to ensure the right analysis at the right time. Expect comprehensive capabilities spanning the full PK lifecycle, from study design consultation and data standardization to analysis, modeling, and submission support, so you always have a clear, consistent view of your evidence and its implications for decision making.

We employ proven methodologies and robust technologies to deliver timely, reproducible outputs that stand up to FDA and EMA scrutiny. Transparency and open communication are central to our approach. Clear diagnostics, documented assumptions, and reviewer friendly deliverables ensure your teams, and regulators, can follow the science every step of the way.

Industry Preferred PK Platforms and Standards

  • Phoenix® WinNonlin® (NCA)
  • Phoenix® NLME (population PK)
  • CDISC SDTM and ADaM (standardized datasets and analysis-ready data)

Related Services

Our PK Capabilities:

Noncompartmental Analysis (NCA)

PK parameter estimation using Phoenix WinNonlin with publication-quality outputs.

Population PK and Simulation

Model-based analyses using Phoenix NLME to quantify variability, explore covariates, and run simulations that inform dose selection and labeling strategies.

Exposure-Response Analysis

PK and PD analysis to link exposure with efficacy and safety endpoints, supporting dose justification and benefit-risk assessment.

CDISC Data Standards

Creation of SDTM and ADaM datasets for traceable, analysis-ready data flows that align with CDISC best practices to support submissions.

Consultancy and Regulatory Support

Contribution to protocol design, SAP and CSR, and production of outputs aligned with FDA and EMA expectations, including comprehensive Tables, Figures, and Listings (TFLs) and a submission-ready PK report.

Case Study Highlights

  • Preclinical and clinical Phase I, II, and III NCA reports accepted by FDA and EMA
  • Independent popPK model review for third-party sponsors
  • Phase III popPK model for a rare disease compound accepted by FDA and EMA
  • Preclinical and clinical simulations supporting informed dosing regimen recommendations
  • Regulatory-ready PK packages prepared for submission, including CDISC SDTM and ADaM datasets and complete documentation
  • Consultation on PK strategy and interpretation, including pediatric and special populations

View the Latest News & Insights

Explore our expert insights, industry news, and valuable resources for biotech innovation.

View News, Events & Blogs

Your Collaborative PK Partner

At Evestia Clinical, we combine scientific rigor with a collaborative, sponsor focused approach. Our PK specialists work as an extension of your team to deliver clear analyses, robust modeling, and submission ready outputs that support confident decision making throughout development.

Learn about Evestia Clinical

Partner With Us

When every decision matters, we make sure you get it right.

 

Contact us